25 XP   0   0   10

Hua Medicine
Buy, Hold or Sell?

Let's analyse Hua Medicine together

PenkeI guess you are interested in Hua Medicine. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hua Medicine. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Hua Medicine

I send you an email if I find something interesting about Hua Medicine.

Quick analysis of Hua Medicine (30 sec.)










What can you expect buying and holding a share of Hua Medicine? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
HK$0.31
Expected worth in 1 year
HK$-0.45
How sure are you?
14.3%

+ What do you gain per year?

Total Gains per Share
HK$-0.75
Return On Investment
-47.4%

For what price can you sell your share?

Current Price per Share
HK$1.59
Expected price per share
HK$1.29 - HK$1.74
How sure are you?
50%

1. Valuation of Hua Medicine (5 min.)




Live pricePrice per Share (EOD)

HK$1.59

Intrinsic Value Per Share

HK$-2.49 - HK$-0.17

Total Value Per Share

HK$-2.18 - HK$0.14

2. Growth of Hua Medicine (5 min.)




Is Hua Medicine growing?

Current yearPrevious yearGrowGrow %
How rich?$38.5m$62.1m-$23.5m-61.1%

How much money is Hua Medicine making?

Current yearPrevious yearGrowGrow %
Making money-$28m-$44.9m$16.8m60.1%
Net Profit Margin-1,156.4%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Hua Medicine (5 min.)




What can you expect buying and holding a share of Hua Medicine? (5 min.)

Welcome investor! Hua Medicine's management wants to use your money to grow the business. In return you get a share of Hua Medicine.

What can you expect buying and holding a share of Hua Medicine?

First you should know what it really means to hold a share of Hua Medicine. And how you can make/lose money.

Speculation

The Price per Share of Hua Medicine is HK$1.59. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hua Medicine.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hua Medicine, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$0.31. Based on the TTM, the Book Value Change Per Share is HK$-0.19 per quarter. Based on the YOY, the Book Value Change Per Share is HK$-0.31 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hua Medicine.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps-0.03-1.8%-0.03-1.8%-0.05-2.9%-0.14-8.8%-0.11-7.0%
Usd Book Value Change Per Share-0.02-1.5%-0.02-1.5%-0.04-2.5%0.032.1%0.010.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.02-1.5%-0.02-1.5%-0.04-2.5%0.032.1%0.010.4%
Usd Price Per Share0.48-0.48-0.48-0.68-0.49-
Price to Earnings Ratio-16.65--16.65--10.54--10.66--7.61-
Price-to-Total Gains Ratio-19.84--19.84--12.17--11.59--11.59-
Price to Book Ratio12.12-12.12-7.62-7.31-5.22-
Price-to-Total Gains Ratio-19.84--19.84--12.17--11.59--11.59-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.203043
Number of shares4925
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.020.03
Usd Total Gains Per Share-0.020.03
Gains per Quarter (4925 shares)-118.55160.59
Gains per Year (4925 shares)-474.18642.35
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-474-4840642632
20-948-958012851274
30-1423-1432019271916
40-1897-1906025692558
50-2371-2380032123200
60-2845-2854038543842
70-3319-3328044964484
80-3793-3802051395126
90-4268-4276057815768
100-4742-4750064236410

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.07.00.00.0%0.07.00.00.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%1.06.00.014.3%1.06.00.014.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.07.00.0%0.00.07.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%1.06.00.014.3%1.06.00.014.3%

Fundamentals of Hua Medicine

About Hua Medicine

Hua Medicine (Shanghai) Ltd. operates as a drug development company that focuses on therapies for the treatment of diabetes in China. It develops Dorzagliatin or HMS5552, an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin for treatment of T2D. The company also offers Dorzagliatin in combination with Pioglitazone for NASH; in combination with GLP-1 for Alzheimer diseases; and in combination with insulin for late stage T2D and Type 1 Diabetes. In addition, it is developing mGLUR5 for the treatment of Parkinson's disease; and Fructokinase Inhibitor for Metabolic disease. The company was incorporated in 2011 and is based in Beijing, China.

Fundamental data was last updated by Penke on 2024-04-16 08:45:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Hua Medicine.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Hua Medicine earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Hua Medicine to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -1,156.4% means that $-11.56 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hua Medicine:

  • The MRQ is -1,156.4%. The company is making a huge loss. -2
  • The TTM is -1,156.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,156.4%TTM-1,156.4%0.0%
TTM-1,156.4%YOY--1,156.4%
TTM-1,156.4%5Y-231.3%-925.1%
5Y-231.3%10Y-165.2%-66.1%
1.1.2. Return on Assets

Shows how efficient Hua Medicine is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hua Medicine to the Drug Manufacturers - Specialty & Generic industry mean.
  • -18.1% Return on Assets means that Hua Medicine generated $-0.18 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hua Medicine:

  • The MRQ is -18.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -18.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-18.1%TTM-18.1%0.0%
TTM-18.1%YOY-36.1%+17.9%
TTM-18.1%5Y-72.5%+54.4%
5Y-72.5%10Y-90.4%+17.9%
1.1.3. Return on Equity

Shows how efficient Hua Medicine is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hua Medicine to the Drug Manufacturers - Specialty & Generic industry mean.
  • -72.8% Return on Equity means Hua Medicine generated $-0.73 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hua Medicine:

  • The MRQ is -72.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -72.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-72.8%TTM-72.8%0.0%
TTM-72.8%YOY-72.3%-0.5%
TTM-72.8%5Y-99.1%+26.3%
5Y-99.1%10Y-70.8%-28.3%

1.2. Operating Efficiency of Hua Medicine.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Hua Medicine is operating .

  • Measures how much profit Hua Medicine makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hua Medicine to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -1,517.8% means the company generated $-15.18  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hua Medicine:

  • The MRQ is -1,517.8%. The company is operating very inefficient. -2
  • The TTM is -1,517.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,517.8%TTM-1,517.8%0.0%
TTM-1,517.8%YOY--1,517.8%
TTM-1,517.8%5Y-303.6%-1,214.2%
5Y-303.6%10Y-216.8%-86.7%
1.2.2. Operating Ratio

Measures how efficient Hua Medicine is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 15.24 means that the operating costs are $15.24 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Hua Medicine:

  • The MRQ is 15.238. The company is inefficient in keeping operating costs low. -1
  • The TTM is 15.238. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ15.238TTM15.2380.000
TTM15.238YOY-+15.238
TTM15.2385Y3.048+12.191
5Y3.04810Y2.177+0.871

1.3. Liquidity of Hua Medicine.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Hua Medicine is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 4.99 means the company has $4.99 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Hua Medicine:

  • The MRQ is 4.991. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.991. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.991TTM4.9910.000
TTM4.991YOY6.592-1.601
TTM4.9915Y10.137-5.146
5Y10.13710Y9.282+0.856
1.3.2. Quick Ratio

Measures if Hua Medicine is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hua Medicine to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.06 means the company can pay off $0.06 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hua Medicine:

  • The MRQ is 0.059. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.059. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.059TTM0.0590.000
TTM0.059YOY6.408-6.349
TTM0.0595Y9.023-8.964
5Y9.02310Y8.560+0.462

1.4. Solvency of Hua Medicine.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Hua Medicine assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hua Medicine to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.75 means that Hua Medicine assets are financed with 75.1% credit (debt) and the remaining percentage (100% - 75.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hua Medicine:

  • The MRQ is 0.751. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.751. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.751TTM0.7510.000
TTM0.751YOY0.502+0.249
TTM0.7515Y0.371+0.380
5Y0.37110Y1.518-1.147
1.4.2. Debt to Equity Ratio

Measures if Hua Medicine is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hua Medicine to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 301.1% means that company has $3.01 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hua Medicine:

  • The MRQ is 3.011. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.011. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ3.011TTM3.0110.000
TTM3.011YOY1.006+2.005
TTM3.0115Y0.980+2.032
5Y0.98010Y0.700+0.280

2. Market Valuation of Hua Medicine

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Hua Medicine generates.

  • Above 15 is considered overpriced but always compare Hua Medicine to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -16.65 means the investor is paying $-16.65 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hua Medicine:

  • The EOD is -7.078. Based on the earnings, the company is expensive. -2
  • The MRQ is -16.648. Based on the earnings, the company is expensive. -2
  • The TTM is -16.648. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.078MRQ-16.648+9.570
MRQ-16.648TTM-16.6480.000
TTM-16.648YOY-10.540-6.108
TTM-16.6485Y-10.658-5.990
5Y-10.65810Y-7.613-3.045
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hua Medicine:

  • The EOD is -5.592. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -13.153. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -13.153. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.592MRQ-13.153+7.561
MRQ-13.153TTM-13.1530.000
TTM-13.153YOY-12.577-0.576
TTM-13.1535Y-63.378+50.225
5Y-63.37810Y-45.270-18.108
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Hua Medicine is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Hua Medicine:

  • The EOD is 5.152. Based on the equity, the company is overpriced. -1
  • The MRQ is 12.118. Based on the equity, the company is expensive. -2
  • The TTM is 12.118. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD5.152MRQ12.118-6.966
MRQ12.118TTM12.1180.000
TTM12.118YOY7.624+4.494
TTM12.1185Y7.308+4.810
5Y7.30810Y5.220+2.088
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Hua Medicine compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.188-0.1880%-0.311+65%0.255-174%0.044-528%
Book Value Per Share--0.3090.3090%0.497-38%0.867-64%0.383-19%
Current Ratio--4.9914.9910%6.592-24%10.137-51%9.282-46%
Debt To Asset Ratio--0.7510.7510%0.502+50%0.371+102%1.518-51%
Debt To Equity Ratio--3.0113.0110%1.006+199%0.980+207%0.700+330%
Dividend Per Share----0%-0%-0%-0%
Eps---0.225-0.2250%-0.360+60%-1.093+387%-0.874+289%
Free Cash Flow Per Share---0.284-0.2840%-0.301+6%-0.260-9%-0.227-20%
Free Cash Flow To Equity Per Share---0.261-0.2610%-0.308+18%0.065-502%0.053-591%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.167--------
Intrinsic Value_10Y_min---2.490--------
Intrinsic Value_1Y_max---0.163--------
Intrinsic Value_1Y_min---0.260--------
Intrinsic Value_3Y_max---0.379--------
Intrinsic Value_3Y_min---0.777--------
Intrinsic Value_5Y_max---0.460--------
Intrinsic Value_5Y_min---1.285--------
Market Cap1556167954.560-135%3660420220.1603660420220.1600%3709356319.360-1%5212673286.784-30%3723338061.989-2%
Net Profit Margin---11.564-11.5640%--100%-2.313-80%-1.652-86%
Operating Margin---15.178-15.1780%--100%-3.036-80%-2.168-86%
Operating Ratio--15.23815.2380%-+100%3.048+400%2.177+600%
Pb Ratio5.152-135%12.11812.1180%7.624+59%7.308+66%5.220+132%
Pe Ratio-7.078+57%-16.648-16.6480%-10.540-37%-10.658-36%-7.613-54%
Price Per Share1.590-135%3.7403.7400%3.790-1%5.326-30%3.804-2%
Price To Free Cash Flow Ratio-5.592+57%-13.153-13.1530%-12.577-4%-63.378+382%-45.270+244%
Price To Total Gains Ratio-8.435+57%-19.842-19.8420%-12.168-39%-11.587-42%-11.587-42%
Quick Ratio--0.0590.0590%6.408-99%9.023-99%8.560-99%
Return On Assets---0.181-0.1810%-0.361+99%-0.725+300%-0.904+398%
Return On Equity---0.728-0.7280%-0.723-1%-0.991+36%-0.708-3%
Total Gains Per Share---0.188-0.1880%-0.311+65%0.255-174%0.044-528%
Usd Book Value--38572836.22638572836.2260%62130853.103-38%108345934.232-64%45682634.631-16%
Usd Book Value Change Per Share---0.024-0.0240%-0.040+65%0.033-174%0.006-528%
Usd Book Value Per Share--0.0390.0390%0.063-38%0.111-64%0.049-19%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.029-0.0290%-0.046+60%-0.140+387%-0.112+289%
Usd Free Cash Flow---35537698.433-35537698.4330%-37662391.465+6%-32514618.963-9%-28700266.754-19%
Usd Free Cash Flow Per Share---0.036-0.0360%-0.038+6%-0.033-9%-0.029-20%
Usd Free Cash Flow To Equity Per Share---0.033-0.0330%-0.039+18%0.008-502%0.007-591%
Usd Market Cap198722647.797-135%467435662.114467435662.1140%473684801.982-1%665658378.722-30%475470270.516-2%
Usd Price Per Share0.203-135%0.4780.4780%0.484-1%0.680-30%0.486-2%
Usd Profit---28077266.550-28077266.5500%-44940568.837+60%-136597646.357+387%-110066450.732+292%
Usd Revenue--2428082.6412428082.6410%-+100%485616.528+400%346868.949+600%
Usd Total Gains Per Share---0.024-0.0240%-0.040+65%0.033-174%0.006-528%
 EOD+3 -5MRQTTM+0 -0YOY+17 -165Y+8 -2510Y+8 -25

3.2. Fundamental Score

Let's check the fundamental score of Hua Medicine based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.078
Price to Book Ratio (EOD)Between0-15.152
Net Profit Margin (MRQ)Greater than0-11.564
Operating Margin (MRQ)Greater than0-15.178
Quick Ratio (MRQ)Greater than10.059
Current Ratio (MRQ)Greater than14.991
Debt to Asset Ratio (MRQ)Less than10.751
Debt to Equity Ratio (MRQ)Less than13.011
Return on Equity (MRQ)Greater than0.15-0.728
Return on Assets (MRQ)Greater than0.05-0.181
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Hua Medicine based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.431
Ma 20Greater thanMa 501.511
Ma 50Greater thanMa 1001.552
Ma 100Greater thanMa 2001.786
OpenGreater thanClose1.590
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,121,497
Total Liabilities841,917
Total Stockholder Equity279,580
 As reported
Total Liabilities 841,917
Total Stockholder Equity+ 279,580
Total Assets = 1,121,497

Assets

Total Assets1,121,497
Total Current Assets940,257
Long-term Assets181,240
Total Current Assets
Cash And Cash Equivalents 490,632
Net Receivables 11,121
Inventory 1,915
Other Current Assets 9,268
Total Current Assets  (as reported)940,257
Total Current Assets  (calculated)512,936
+/- 427,321
Long-term Assets
Property Plant Equipment 139,708
Intangible Assets 31,952
Other Assets 9,580
Long-term Assets  (as reported)181,240
Long-term Assets  (calculated)181,240
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities188,386
Long-term Liabilities653,531
Total Stockholder Equity279,580
Total Current Liabilities
Short Long Term Debt 33,923
Accounts payable 20,982
Other Current Liabilities 73,649
Total Current Liabilities  (as reported)188,386
Total Current Liabilities  (calculated)128,554
+/- 59,832
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt63,659
Long-term Liabilities  (as reported)653,531
Long-term Liabilities  (calculated)63,659
+/- 589,872
Total Stockholder Equity
Other Stockholders Equity 272,950
Total Stockholder Equity (as reported)279,580
Total Stockholder Equity (calculated)272,950
+/- 6,630
Other
Capital Stock7,214
Common Stock Shares Outstanding 970,111
Net Invested Capital 313,503
Net Tangible Assets 247,628
Net Working Capital 751,871
Property Plant and Equipment Gross 173,942



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
226,732
245,784
1,490,249
1,254,613
1,198,521
903,553
1,121,497
1,121,497903,5531,198,5211,254,6131,490,249245,784226,732
   > Total Current Assets 
224,541
232,288
1,474,510
1,120,452
1,045,277
704,600
940,257
940,257704,6001,045,2771,120,4521,474,510232,288224,541
       Cash And Cash Equivalents 
192,901
172,733
1,443,310
1,105,600
1,032,090
675,238
490,632
490,632675,2381,032,0901,105,6001,443,310172,733192,901
       Short-term Investments 
30,000
16,101
0
0
0
0
0
0000016,10130,000
       Net Receivables 
426
961
1,650
10,552
9,227
9,701
11,121
11,1219,7019,22710,5521,650961426
       Other Current Assets 
1,214
42,493
29,550
4,300
3,960
19,661
9,268
9,26819,6613,9604,30029,55042,4931,214
   > Long-term Assets 
2,191
13,496
15,739
134,161
153,244
198,953
181,240
181,240198,953153,244134,16115,73913,4962,191
       Property Plant Equipment 
878
2,641
5,328
101,474
123,518
156,600
139,708
139,708156,600123,518101,4745,3282,641878
       Intangible Assets 
0
0
859
1,980
3,387
9,026
31,952
31,9529,0263,3871,98085900
       Other Assets 
1,313
10,855
9,552
30,707
26,339
33,327
9,580
9,58033,32726,33930,7079,55210,8551,313
> Total Liabilities 
892,928
1,188,314
86,761
193,993
466,026
453,222
841,917
841,917453,222466,026193,99386,7611,188,314892,928
   > Total Current Liabilities 
25,281
42,997
77,633
108,786
106,547
106,884
188,386
188,386106,884106,547108,78677,63342,99725,281
       Short-term Debt 
30,000
16,101
0
0
0
0
0
0000016,10130,000
       Short Long Term Debt 
0
0
0
0
0
0
33,923
33,923000000
       Accounts payable 
10,469
8,348
55,676
51,601
25,821
23,785
20,982
20,98223,78525,82151,60155,6768,34810,469
       Other Current Liabilities 
10,482
26,649
7,090
16,589
24,555
37,654
73,649
73,64937,65424,55516,5897,09026,64910,482
   > Long-term Liabilities 
867,647
1,145,317
9,128
85,207
359,479
346,338
653,531
653,531346,338359,47985,2079,1281,145,317867,647
       Long term Debt Total 
855,488
1,138,789
0
77,959
69,212
58,232
0
058,23269,21277,95901,138,789855,488
       Other Liabilities 
12,159
6,528
9,128
7,248
290,267
288,106
0
0288,106290,2677,2489,1286,52812,159
> Total Stockholder Equity
-670,142
-953,880
1,403,488
1,060,620
732,495
450,331
279,580
279,580450,331732,4951,060,6201,403,488-953,880-670,142
   Common Stock
48
48
7,209
7,209
7,209
7,211
0
07,2117,2097,2097,2094848
   Retained Earnings 
-676,560
-949,274
-4,552,000
-4,977,270
725,976
-5,696,138
-5,899,645
-5,899,645-5,696,138725,976-4,977,270-4,552,000-949,274-676,560
   Capital Surplus 
0
0
5,886,048
5,893,318
5,899,838
5,910,257
0
05,910,2575,899,8385,893,3185,886,04800
   Treasury Stock0-626-690-729-79700
   Other Stockholders Equity 
6,370
-4,654
63,028
138,092
725,976
229,627
272,950
272,950229,627725,976138,09263,028-4,6546,370



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue17,599
Cost of Revenue-9,910
Gross Profit7,6897,689
 
Operating Income (+$)
Gross Profit7,689
Operating Expense-258,272
Operating Income-240,673-250,583
 
Operating Expense (+$)
Research Development129,528
Selling General Administrative145,279
Selling And Marketing Expenses-
Operating Expense258,272274,807
 
Net Interest Income (+$)
Interest Income4,240
Interest Expense-3,667
Other Finance Cost-0
Net Interest Income573
 
Pretax Income (+$)
Operating Income-240,673
Net Interest Income573
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-203,507-240,673
EBIT - interestExpense = -270,785
-203,507
-199,840
Interest Expense3,667
Earnings Before Interest and Taxes (EBIT)-267,118-199,840
Earnings Before Interest and Taxes (EBITDA)-168,063
 
After tax Income (+$)
Income Before Tax-203,507
Tax Provision-0
Net Income From Continuing Ops-203,507-203,507
Net Income-203,507
Net Income Applicable To Common Shares-203,507
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--573
 

Technical Analysis of Hua Medicine
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hua Medicine. The general trend of Hua Medicine is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hua Medicine's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hua Medicine.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.73 < 1.73 < 1.74.

The bearish price targets are: 1.29 > 1.29.

Tweet this
Hua Medicine Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hua Medicine. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hua Medicine Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hua Medicine. The current macd is 0.00071127.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hua Medicine price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Hua Medicine. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Hua Medicine price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Hua Medicine Daily Moving Average Convergence/Divergence (MACD) ChartHua Medicine Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hua Medicine. The current adx is 12.27.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Hua Medicine shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Hua Medicine Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hua Medicine. The current sar is 1.43040979.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Hua Medicine Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hua Medicine. The current rsi is 54.43. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
Hua Medicine Daily Relative Strength Index (RSI) ChartHua Medicine Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hua Medicine. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hua Medicine price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Hua Medicine Daily Stochastic Oscillator ChartHua Medicine Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hua Medicine. The current cci is 86.04.

Hua Medicine Daily Commodity Channel Index (CCI) ChartHua Medicine Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hua Medicine. The current cmo is 17.32.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Hua Medicine Daily Chande Momentum Oscillator (CMO) ChartHua Medicine Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hua Medicine. The current willr is -31.81818182.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Hua Medicine is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Hua Medicine Daily Williams %R ChartHua Medicine Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hua Medicine.

Hua Medicine Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hua Medicine. The current atr is 0.09457386.

Hua Medicine Daily Average True Range (ATR) ChartHua Medicine Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hua Medicine. The current obv is -96,511,335.

Hua Medicine Daily On-Balance Volume (OBV) ChartHua Medicine Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hua Medicine. The current mfi is 74.03.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Hua Medicine Daily Money Flow Index (MFI) ChartHua Medicine Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hua Medicine.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Hua Medicine Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hua Medicine based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.431
Ma 20Greater thanMa 501.511
Ma 50Greater thanMa 1001.552
Ma 100Greater thanMa 2001.786
OpenGreater thanClose1.590
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Hua Medicine with someone you think should read this too:
  • Are you bullish or bearish on Hua Medicine? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hua Medicine? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hua Medicine

I send you an email if I find something interesting about Hua Medicine.


Comments

How you think about this?

Leave a comment

Stay informed about Hua Medicine.

Receive notifications about Hua Medicine in your mailbox!